- Home
- RPTX vs ERH Comparison
RPTX vs ERH Comparison
Compare RPTX & ERH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPTX | ERH |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.4M | 108.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPTX | ERH |
|---|---|---|
| Price | $2.18 | $11.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 23.2K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,870,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $7.97 |
| 52 Week High | $4.07 | $10.91 |
Technical Indicators
Market Signals| Indicator | RPTX | ERH |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 30.73 |
| Support Level | $2.15 | $11.91 |
| Resistance Level | $2.24 | $12.55 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 57.35 | 7.80 |
Price Performance
Historical ComparisonAbout RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About ERH Allspring Utilities and High Income Fund
Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.